FDA panel endorses Moderna's mRNA flu shot for older adults

Jun 18, 2026, 10:35 PM10

(Update: Jun 18, 2026, 10:35 PM)

Food and Drug Administration

agency of the US Department of Health and Human Services

Moderna

American biotechnology company

science

informative

innovative

FDA panel endorses Moderna's mRNA flu shot for older adults

An FDA advisory panel recommended the approval of Moderna's mRNA flu vaccine for older adults after a trial showed it was 27% more effective than standard flu shots.
The panel's endorsement includes a requirement for Moderna to conduct an additional clinical trial for older adults after the vaccine is available.
The approval process remains uncertain due to the lack of permanent leadership at the FDA, which could affect the vaccine's availability this fall.

Food and Drug Administration

agency of the US Department of Health and Human Services

Moderna

American biotechnology company

Insights

News 1

Related reports

Opinions

Story

“

analysis insight economic global shift economic insight strategic trends market policy strategic economic insight market strategic geopolitical impact geopolitical impact geopolitical insight policy insight strategic policy trends impact strategic economic analysis insight geopolitical trends shift geopolitical economic impact strategic geopolitical economic shift analysis policy global shift impact insight shift data strategic economic economic analysis economic trends economic insight analysis policy data analysis global impact economic market trends insight shift global analysis policy strategic policy geopolitical analysis policy impact policy impact...